Logotype for P3 Health Partners Inc

P3 Health Partners (PIII) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for P3 Health Partners Inc

Proxy filing summary

30 Apr, 2026

Voting matters and shareholder proposals

  • Election of three Class II directors to serve until the 2029 Annual Meeting, with nominees Amir Bacchus, M.D., Mark Thierer, and Lawrence B. Leisure recommended for election.

  • Ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

  • Advisory approval of executive compensation for named executive officers.

  • Approval of the issuance of up to 3,341,130 shares of Class A common stock upon exercise of outstanding warrants held by VBC Growth SPV 5, LLC, in accordance with Nasdaq Listing Rule 5635(d).

  • Consideration of any other business that may properly come before the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends all director nominees for election to serve until 2029, ensuring continuity in governance.

Executive compensation and say-on-pay

  • Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more